There is conflicting information about whether the characteristic metabolite signatures of AD precede its clinical onset and whether or not the APOE alleles influence the normal aging process (Gomar et al., 2014, Kantarci et al., 2002, Kantarci et al., 2000). Here, APOE is linked to Alzheimer disease.